HomePress ReleaseOne80 Intermediaries Launches GeneBridge Gene Therapy Reinsurance Product

One80 Intermediaries Launches GeneBridge Gene Therapy Reinsurance Product

The solution mitigates the financial impact of high-cost gene therapy claims.BOSTON–(BUSINESS WIRE)–One80 Intermediaries (One80), a specialty insurance broker headquartered in Boston, today announced the launch of GeneBridge, an innovative product created to mitigate the financial impact of high-cost gene therapy claims.
GeneBridge is a reinsurance facility designed for blocks of business including employer stop loss programs and health plans. Programs that purchase GeneBridge are reimbursed up to a scheduled amount for the list price and administration of the FDA-approved therapies.
More than 10,000 diseases are linked to genetic disorders fueling a rapid growth in approved treatments. At an average cost per therapy of over $2.5 million, related high-cost claims are expected to grow at an equally rapid pace.
“With the number of gene and cell therapies expected to double over the next two years, we saw a great need to mitigate the potentially catastrophic financial impact one or more of these claims would have on programs and employer groups,” said Matthew Power, President of One80 Intermediaries. “With GeneBridge, One80 is at the forefront of providing clients with protection for a rapidly growing area of high-cost claims,” he continued.
The program will be administered through One80’s medical stop loss practice, a full-service Managing General Underwriter.
About One80 Intermediaries
One80 Intermediaries is a privately held firm with offices throughout the US and Canada. As a leading insurance wholesaler and program manager, the company offers placement services and binding authority for property & casualty, professional and personal lines, life insurance, and travel/accident and health coverages. One80 specializes in key industry verticals such as medical stop loss, cannabis captives, alternative risk, warranty coverage and lender-based insurance. One80 serves commercial companies, non-profits, public entities, individuals and associations and unions, and has access to all major insurance markets in the US, Canada, and UK. One80 has offices in more than 40 locations in the US and Canada. For more information visit www.one80intermediaries.com Contacts
Media Contact:
Lenika P. Milne
lmilne@one80intermediaries.com(786) 865-4614

RELATED:  Organigram Invests in Sanity Group, a Leading German Cannabis Company

Keep exploring...

Related Articles

Luxury Cannabis Cigar Brand Launches Hand-Rolled Cannagar in New York Market

Colorado-Based Cannabis Brand, Made in Xiaolin, Expands Product Offerings to New York, Returns to...

Epilepsy Drugs Market, Size, Global Research 2024-2030 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott Laboratories, Alkem Laboratories, Bausch, GSK, Novartis, and Pfizer –...

DUBLIN--(BUSINESS WIRE)--The "Epilepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight,...

NJOY Receives First FDA Authorizations for Menthol E-Vapor Products

RICHMOND, Va.--(BUSINESS WIRE)--$MO--Altria Group, Inc. (Altria) (NYSE: MO) announces today that the U.S. Food...

Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year

The fifth annual Report on Business editorial benchmark identifies top-level Canadian businesses with the...

One80 Intermediaries Offers Liability Insurance for Chief Restructuring Officers

The policy covers gaps between the distressed company’s insurance and that of their Chief...

Life Is Chill Expands Line of THC Soft Gels with New Live Resin THC Capsules, A First Of Its Kind for the Arizona Market

The new plant-based soft gel will launch on Friday, January 19, providing Arizona consumers...